In vitro characterization of 6-[18F]fluoro-A85380, a high-affinity ligand for α4β2*nicotinic acetylcholine receptors

被引:20
作者
Gündisch, D [1 ]
Koren, AO [1 ]
Horti, AG [1 ]
Pavlova, OA [1 ]
Kimes, AS [1 ]
Mukhin, AG [1 ]
London, ED [1 ]
机构
[1] Natl Inst Drug Abuse, Neuroimaging Res Branch, NIH, DHHS,Intramural Res Program, Baltimore, MD 21224 USA
关键词
6-[F-18]fluoro-A-85380; nicotine; epibatidine; cytisine; receptor binding; nicotinic acetylcholine receptor;
D O I
10.1002/syn.20096
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Nicotinic acetylcholine receptors are involved in tobacco dependence and several other neuropathologies (e.g., Alzheimer's disease, Parkinson's disease), as well as in attention, learning, and memory. Performing in vivo imaging of these receptors in humans holds great promise for understanding their role in these conditions. Recently, three radiohalogenated analogs of 3-(2(S)-azetidinylmethoxy)pyridine (A-85380) were used successfully for the in vivo visualization of alpha4beta2* nicotinic receptors in the human brain with PET/SPECT. Herein, we present the results of the in vitro characterization of one of these radioligands, 6-[F-18]fluoro-3-(2(S)-azetidinylmethoxy)-pyridine (6-[F-18]fluoro-A-85380), which is a fluoro-analog of the potent nonopioid analgesic ABT-594. In human postmortem cortical tissue, 6- [F-18]fluoro-A-85380 reversibly binds with high affinity to a single population of sites (K-d = 59 pM at 37degreesC, B-max = 0.7 pmol/g tissue). The binding is fully reversible and is characterized at 37degreesC by T-1/2assoc = 2.2 min (at a ligand concentration of 39 pM) and by T-1/2dissoc = 3.6 min. 6-Fluoro-A-85380 exhibits clear selectivity for alpha4beta2* over the other major mammalian nicotinic receptor subtypes: alpha7, alpha3beta4, and muscle-type. These results suggest that 6-[F-18]fluoro-A-85380 is a promising radioligand for in vivo imaging of brain alpha4beta2* nicotinic receptors. Published 2004 Wiley-Liss, Inc.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 56 条
[1]   Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors [J].
Bannon, AW ;
Decker, MW ;
Holladay, MW ;
Curzon, P ;
Donnelly-Roberts, D ;
Puttfarcken, PS ;
Bitner, RS ;
Diaz, A ;
Dickenson, AH ;
Porsolt, RD ;
Williams, M ;
Arneric, SP .
SCIENCE, 1998, 279 (5347) :77-81
[2]  
Bottlaender M, 2003, J NUCL MED, V44, P596
[3]   Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia [J].
Breese, CR ;
Lee, MJ ;
Adams, CE ;
Sullivan, B ;
Logel, J ;
Gillen, KM ;
Marks, MJ ;
Collins, AC ;
Leonard, S .
NEUROPSYCHOPHARMACOLOGY, 2000, 23 (04) :351-364
[4]   Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors [J].
Brown, LL ;
Kulkarni, S ;
Pavlova, OA ;
Koren, AO ;
Mukhin, AG ;
Newman, AH ;
Horti, AG .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) :2841-2849
[5]   Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice [J].
Champtiaux, N ;
Han, ZY ;
Bessis, A ;
Rossi, FM ;
Zoli, M ;
Marubio, L ;
McIntosh, JM ;
Changeux, JP .
JOURNAL OF NEUROSCIENCE, 2002, 22 (04) :1208-1217
[6]  
CHATTOPADHYAY S, 2003, J NUCL MED, V44
[7]   NEURONAL-TYPE ALPHA-BUNGAROTOXIN RECEPTORS AND THE ALPHA-5-NICOTINIC RECEPTOR SUBUNIT GENE ARE EXPRESSED IN NEURONAL AND NONNEURONAL HUMAN CELL-LINES [J].
CHINI, B ;
CLEMENTI, F ;
HUKOVIC, N ;
SHER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (05) :1572-1576
[8]  
Clementi Francesco, 2000, Trends in Pharmacological Sciences, V21, P35, DOI 10.1016/S0165-6147(99)01423-6
[9]   Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine an colonic motility in patients and healthy subjects [J].
Coulie, B ;
Camilleri, M ;
Bharucha, AE ;
Sandborn, WJ ;
Burton, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (05) :653-663
[10]  
Criado M, 1997, J NEUROSCI, V17, P6554